For instance, mutations in PBRM1 associate with increased CTL infiltration and PD-L1 expression, as well as with decreased infiltration by regulatory T cells in clear cell renal cell carcinoma [84,85]. The gene discussed is PBRM1; the disease is clear cell renal carcinoma.